Skip to main content

#151580

Anti-ENTPD1 [AC2]

Cat. #151580

Anti-ENTPD1 [AC2]

Cat. #: 151580

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1, CD39)

Class: Monoclonal

Application: FACS ; IF ; IP ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Martin Rowe

Institute: University of Birmingham

Primary Citation: Rowe et al. 1982. Int J Cancer. 29(4):373-81. PMID: 6282762.

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-ENTPD1 [AC2]
  • Research fields: Cell biology;Immunology;Neurobiology;Tissue-specific biology
  • Clone: AC2
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 70-100 kDa
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS ; IF ; IP ; WB
  • Description: Monoclonal antibody which binds ENTPD1, and reacts with Epstein Barr lymphoblastoid cell lines. ACE2 reacted consistently with all Epstein Barr virus lymphoblastoid cell line (EB-LCL) tested, with a subpopulation of cells in some but not all EB virus genome-positive Burkitt lymphoma lines, but with none of a range of EB virus genome-negative cell lines of lymphoma or leukaemia origin.
  • Immunogen: EBV-transformed human B lymphoblastoid cell line
  • Immunogen uniprot id: O75356
  • Isotype: IgG1
  • Myeloma used: P3X63Ag8.653
  • Recommended controls: EBV-transformed human B lymphoblastoid cell line as positive control

Target Details

  • Target: Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1, CD39)
  • Molecular weight: 70-100 kDa
  • Tissue cell line specificity: EBV-transformed human B lymphoblastoid cell line
  • Target background: ENTPD1 is a transmembrane glycoprotein of apparent molecular weight of 70-100 kD that has an Ectonucleoside triphosphate diphosphohydrolase-1 (NTPDase-1, ecto-apyrase) activity hydrolysing the alpha- and beta- phosphate residues of extracellular ATP or ADP. In haematopoietic tissues, it is primarily expressed on activated B, T and NK cells. It is also expressed on some endothelial cells and cardiac neurons, and helps regulate platelet activation, vascular inflammation, and cardiac norepinephrine release.

Applications

  • Application: FACS ; IF ; IP ; WB
  • Application notes: Recommended Concentrations: FACS: 1ug/5x10^5 cells Immunofluorescence on acetone-fixed frozen sections or cell smears: 1-2ug/ml Western blot (ECL): 0.2ug/ml

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: Store at -20° C frozen. Avoid repeated freeze / thaw cycles
  • Shipping conditions: Dry ice

References

  • Rowe et al. 1982. Int J Cancer. 29(4):373-81. PMID: 6282762.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.